New Quinazolin‐4(3 H )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches
Journal of Biochemical and Molecular Toxicology · 2025-08 · 39 (8)
DOI: 10.1002/jbt.70412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 28.07.2025. Verfasst von Feyzi Sinan Tokalı und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Türkiye. Hauptthemen laut MEDLINE: Aldehyde Reductase, Thiazolidinediones, Enzyme Inhibitors, Glycoside Hydrolases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: This study was supported by the Scientific Research Projects Coordinatorship of Kafkas University with project number 2023-FM-65..
Abstract (Originalsprache)
The impact of diabetes and its complications on individuals is profound, leading to severe health issues and reduced quality of life. This study aimed the design, synthesis, and evaluation of new quinazolin‐4(3 H )‐one‐thiazolidine‐2,4‐dione hybrids as dual inhibitors targeting α‐glycosidase (α‐Gly) and aldose reductase (ALR2), two key enzymes implicated in type 2 diabetes mellitus (T2DM) and its complications. Thirteen compounds were synthesized and characterized using FTIR, NMR, and HRMS. In vitro assays revealed potent inhibition of α‐Gly and ALR2, with compound 9 (phenethyl substituted) emerging as the most potent inhibitor for both enzymes (α‐Gly K i = 0.355 µM, ALR2 Ki = 0.106 µM). Molecular docking and dynamics simulations confirmed the stable binding of compound 9 in the active sites of both enzymes, with key interactions such as hydrogen bonds and π–π stacking contributing to its potency. The docking score of compound 9 was calculated as –11.120 kcal/mol for α‐Gly and –10.713 kcal/mol for ALR2. Additionally, cytotoxicity studies showed that the compounds exhibited low toxicity towards human healthy cell lines, indicating their potential for therapeutic use. ADME‐T predictions further supported their drug‐like properties, with compounds 8 (cyclohexyl substituted) and 9 demonstrating favorable pharmacokinetic profiles. Overall, this study identifies compound 9 as a promising candidate for further optimization and development as a dual‐target inhibitor for T2DM and its complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Türkiye.
- Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, Ardahan, Türkiye.
- Department of Veterinary Physiology, Faculty of Veterinary Medicine, Kafkas University, Kars, Türkiye.
- Department of Biotechnology, Institute of Health Sciences, Bezmialem Vakif University, Fatih, Istanbul, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Bezmialem Vakif University, Fatih, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Türkiye.
ORCID-Profile: Feyzi Sinan Tokalı, Yeliz Demir, Halil Şenol
Förderung
- This study was supported by the Scientific Research Projects Coordinatorship of Kafkas University with project number 2023-FM-65.
Zitieren
APA
Tokalı, F. S., Demir, Y., Tokalı, P., Ateşoğlu, Ş., & Şenol, H. (2025). New Quinazolin‐4(3 H )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches. Journal of Biochemical and Molecular Toxicology, 39(8). https://doi.org/10.1002/jbt.70412
Vancouver
Tokalı FS, Demir Y, Tokalı P, Ateşoğlu Ş, Şenol H. New Quinazolin‐4(3 H )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches. Journal of Biochemical and Molecular Toxicology. 2025;39(8). doi:10.1002/jbt.70412
BibTeX
@article{Tokal2025,
author = {Tokalı, Feyzi Sinan and Demir, Yeliz and Tokalı, Pelin and Ateşoğlu, Şeyma and Şenol, Halil},
title = {New Quinazolin‐4(3 H )‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {8},
doi = {10.1002/jbt.70412}
}
EUVIMED